ALBZOUR BOGDAN MORAD

(Doctor of Dermatology)

After clinical evaluation, NV Cysteamine 10% Serum has demonstrated significant efficacy in the treatment of melasma and hyperpigmentation, with visible improvement observed as early as day 7 in clinical cases—an important advantage given the complex nature of melasma management. Thanks to NanoVectores technology, the active ingredient penetrates deeply into the skin, is evenly distributed, and released in a controlled manner. This allows Cysteamine to inhibit melanin-producing enzymes at the melanocyte level while enhancing antioxidant activity, thereby effectively supporting skin brightening.

SEE MORE

PUNIT SAKHARE

(Dermatologist)

In the past, melasma treatment primarily focused on reducing melanin using formulations such as hydroquinone and tretinoin. However, due to insufficient control of inflammation and vascular factors, treatment outcomes were often unstable and prone to recurrence. With Anti-Melasma, powered by NV Cysteamine 10% in combination with supportive active ingredients and NanoVectores technology, the treatment protocol takes a comprehensive approach to melasma management. Pigmentation is controlled from the early stages and throughout the entire melanin-formation process, thereby enhancing both treatment efficacy and long-term stability.

SEE MORE

DERMATOLOGIST NGUYEN NHUNG

(Dermatologist – Military Medical Academy)

As a Doctor from the Military Medical Academy, having used many different skin care and treatment methods, the Doctor rates MD Cosmedi as the best skin care and treatment support product line today. 100% of customers are satisfied with MD Cosmedi products, especially sunscreen and anti-aging serum. In addition, the brand’s staff also supports the Doctor a lot.

SEE MORE

CUSTOMER FEEDBACK